P42229

PTMD Annotation Information


※ Protein Information

Tag Content
UniProt Accession STA5A_HUMAN; P42229;
Entrez ID 6776
GenBank Protein ID NM_001288718.1; NM_001288719.1; NM_001288720.1; NM_003152.3;
GenBank Nucleotide ID NP_001275647.1; NP_001275648.1; NP_001275649.1; NP_003143.2;
Protein Name Signal transducer and activator of transcription 5A
Gene Name STAT5A; STAT5
Organism Homo sapiens
NCBI Taxa ID 9606
Functional DescriptionCarries out a dual function: signal transduction and activation of transcription. Mediates cellular responses to the cytokine KITLG/SCF and other growth factors. Mediates cellular responses to ERBB4. May mediate cellular responses to activated FGFR1, FGFR2, FGFR3 and FGFR4. Binds to the GAS element and activates PRL-induced transcription. Regulates the expression of milk proteins during lactation.
Sequence
(Fasta)
MAGWIQAQQL QGDALRQMQV LYGQHFPIEV RHYLAQWIES QPWDAIDLDN PQDRAQATQL 60
LEGLVQELQK KAEHQVGEDG FLLKIKLGHY ATQLQKTYDR CPLELVRCIR HILYNEQRLV 120
REANNCSSPA GILVDAMSQK HLQINQTFEE LRLVTQDTEN ELKKLQQTQE YFIIQYQESL 180
RIQAQFAQLA QLSPQERLSR ETALQQKQVS LEAWLQREAQ TLQQYRVELA EKHQKTLQLL 240
RKQQTIILDD ELIQWKRRQQ LAGNGGPPEG SLDVLQSWCE KLAEIIWQNR QQIRRAEHLC 300
QQLPIPGPVE EMLAEVNATI TDIISALVTS TFIIEKQPPQ VLKTQTKFAA TVRLLVGGKL 360
NVHMNPPQVK ATIISEQQAK SLLKNENTRN ECSGEILNNC CVMEYHQATG TLSAHFRNMS 420
LKRIKRADRR GAESVTEEKF TVLFESQFSV GSNELVFQVK TLSLPVVVIV HGSQDHNATA 480
TVLWDNAFAE PGRVPFAVPD KVLWPQLCEA LNMKFKAEVQ SNRGLTKENL VFLAQKLFNN 540
SSSHLEDYSG LSVSWSQFNR ENLPGWNYTF WQWFDGVMEV LKKHHKPHWN DGAILGFVNK 600
QQAHDLLINK PDGTFLLRFS DSEIGGITIA WKFDSPERNL WNLKPFTTRD FSIRSLADRL 660
GDLSYLIYVF PDRPKDEVFS KYYTPVLAKA VDGYVKPQIK QVVPEFVNAS ADAGGSSATY 720
MDQAPSPAVC PQAPYNMYPQ NPDHVLDQDG EFDLDETMDV ARHVEELLRR PMDSLDSRLS 780
PPAGLFTSAR GSLS 795

※ PTM-Disease Association

NumPTMDiseaseCell TypeTypePTM SitePMID
1PhosphorylationBreast cancer/tumor/carcinomacell lineA22751112; 21576635
[Reference]: Loss of nuclear localized and tyrosine phosphorylated Stat5 in breast cancer predicts poor clinical outcome and increased risk of antiestrogen therapy failure
2PhosphorylationAcute myeloid leukaemia/Acute myelogenous leukemiaP22725130
[Reference]: Expression of phosphorylated signal transducer and activator of transcription 5 is associated with an increased risk of death in acute myeloid leukemia
3Tyrosine PhosphorylationColon cancer/carcinomaAY69423733954
[Reference]: Unphosphorylated STAT5A stabilizes heterochromatin and suppresses tumor growth
4Tyrosine PhosphorylationGlioblastomatumor tissuePY69422729867
[Reference]: Phosphorylation of STAT5b is associated with elevated EGFR and poor outcome
5Tyrosine PhosphorylationLarge granular lymphocytic leukemiatumor tissueCY69423596048
[Reference]: The Y665F and N642H mutant constructs increased the transcriptional activity of STAT5 and tyrosine (Y694) phosphorylation, which was also observed in patient samples
6Serine PhosphorylationLymphomaUS77920508164
[Reference]: Stat5a serine 725 and 779 phosphorylation is a prerequisite for hematopoietic transformation.
7Serine PhosphorylationChronic myelogenous leukemia/Chronic myeloid leukemiaUS77920508164
[Reference]: Stat5a serine 725 and 779 phosphorylation is a prerequisite for hematopoietic transformation.
8Serine PhosphorylationAcute myeloid leukaemia/Acute myelogenous leukemiaUS77920508164
[Reference]: Stat5a serine 725 and 779 phosphorylation is a prerequisite for hematopoietic transformation.

※ Disease Cross-ref Annotation

DatabaseAnnotation
CTD (Curated)
(count: 11)
(view all)
MESH:D000230 ; Adenocarcinoma
MESH:D001943 ; Breast Neoplasms
MESH:D002277 ; Carcinoma
MESH:D044584 ; Carcinoma, Ductal
MESH:D002285 ; Carcinoma, Intraductal, Noninfiltrating
MESH:D018275 ; Carcinoma, Lobular
GWASdb
(count: 1)
rs16967637; Aortic root size; cardiovascular system disease

※ PTM Sites

PTM Modification Sites
Phosphorylation
(count: 24)
(view all)
114       RCIRHILYNEQRLVR     dbPAF
127       VREANNCSSPAGILV     dbPAF
128       REANNCSSPAGILVD     dbPAF
193       FAQLAQLSPQERLSR     dbPAF
22        LRQMQVLYGQHFPIE     dbPAF
245       QLLRKQQTIILDDEL     dbPAF
Acetylation
(count: 3)
347       QVLKTQTKFAATVRL     PLMD
696       KAVDGYVKPQIKQVV     PLMD
84        GEDGFLLKIKLGHYA     PLMD
Ubiquitination
(count: 13)
(view all)
163       QDTENELKKLQQTQE     PLMD
164       DTENELKKLQQTQEY     PLMD
207       RETALQQKQVSLEAW     PLMD
235       ELAEKHQKTLQLLRK     PLMD
242       KTLQLLRKQQTIILD     PLMD
384       QQAKSLLKNENTRNE     PLMD
Sumoylation
(count: 3)
384       QQAKSLLKNENTRNE     PLMD
696       KAVDGYVKPQIKQVV     PLMD
700       GYVKPQIKQVVPEFV     PLMD

※ Protein-Protein Interaction

NetworkInteraction
ABSource
A8CG34P42229IntAct
E9PFC7P42229HPRD
O60674P42229HPRD
P00367P42229IntAct
P00533P42229HPRD
P02751P42229IntAct
P03372P42229HPRD; MINT
P04150P42229HPRD
P06133P42229IntAct
P06213P42229HPRD
P06239P42229HPRD
P09619P42229HPRD; DIP
P10721P42229HPRD
P10912P42229HPRD
P11712P42229IntAct
P12931P42229HPRD
P14784P42229HPRD
P14859P42229HPRD
P16234P42229HPRD
P16410P42229HPRD
P16871P42229HPRD
P17676P42229HPRD
P17706P42229HPRD
P18031P42229HPRD; MINT
P19235P42229HPRD; MINT
P20963P42229HPRD
P22681P42229HPRD
P23284P42229HPRD
P23458P42229HPRD
P27361P42229HPRD
P28482P42229HPRD
P29353P42229HPRD
P31785P42229HPRD
P38159P42229IntAct
P40763P42229HPRD
P42224P42229HPRD
P42229P42229HPRD; IntAct
P42229P43365HPRD; IntAct; MINT
P42229P43405HPRD
P42229P46108HPRD
P42229P46109HPRD
P42229P51587HPRD
P42229P51681HPRD
P42229P51692HPRD
P42229P51813HPRD
P42229P52333HPRD
P42229P60484MINT
P42229P62879MINT
P42229P67775HPRD
P42229P82932IntAct
P42229Q02763HPRD
P42229Q06124HPRD
P42229Q06187HPRD
P42229Q09472HPRD; IntAct
P42229Q13287HPRD; IntAct
P42229Q15303HPRD
P42229Q5SRQ6IntAct
P42229Q6PKC3IntAct
P42229Q6VEQ5IntAct
P42229Q8NBQ7IntAct
P42229Q8TC21IntAct
P42229Q92731HPRD
P42229Q92793IntAct
P42229Q969D9HPRD
P42229Q99490MINT
P42229Q99814IntAct
P42229Q9HC77HPRD
P42229Q9NRG1HPRD; IntAct; MINT
P42229Q9UGK3MINT;HPRD
P42229Q9Y618HPRD